Anal cancer: current standards in care and recent changes in practice

R Shridhar, D Shibata, E Chan… - CA: a cancer journal for …, 2015 - Wiley Online Library
Answer questions and earn CME/CNE The management of squamous cell carcinomas of
the anal canal has evolved from surgery as first‐line treatment to curative chemoradiation …

[PDF][PDF] The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma

N Quartuccio, G Treglia, M Salsano, MV Mattoli… - Radiology and …, 2013 - sciendo.com
The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and
restaging of patients with osteosarcoma Page 1 Radiol Oncol 2013; 47(2): 97-102. doi:10.2478/raon-2013-0017 …

Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer

Z Bao, D Wang, S Chen, M Chen, D Jiang, C Yang… - Radiation …, 2019 - Springer
Background To quantify the dosimetric parameters of different bone marrow sparing
strategies and to determine the optimal strategy for cervical cancer patients undergoing …

[HTML][HTML] Radiation therapy techniques and treatment-related toxicity in the PORTEC-3 trial: Comparison of 3-dimensional conformal radiation therapy versus intensity …

BG Wortman, CCB Post, ME Powell, P Khaw… - International Journal of …, 2022 - Elsevier
Purpose Radiation therapy techniques have developed from 3-dimensional conformal
radiation therapy (3DCRT) to intensity modulated radiation therapy (IMRT), with better …

[HTML][HTML] Pelvic Ewing sarcomas

FS Mounessi, P Lehrich, U Haverkamp… - Strahlentherapie und …, 2013 - infona.pl
Purpose The goal of the present work was to assess the potential advantage of intensity-
modulated radiotherapy (IMRT) over three-dimensional conformal radiotherapy (3D-CRT) …

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in patients with stage IIB-IVA cervical cancer: a randomized phase III trial

S He, Y Wang, Y Lai, X Cao, Y Ren, Y Chen - Frontiers in oncology, 2022 - frontiersin.org
Background In this trial, we aimed to assess the efficacy and safety of radiotherapy with
nedaplatin or cisplatin in patients with locally advanced cervical cancer. Methods We …

[PDF][PDF] Does initial 45Gy of pelvic intensity-modulated radiotherapy reduce late complications in patients with locally advanced cervical cancer? A cohort control study …

SW Chen, JA Liang, LS Yeh, WC Chang… - Radiology and …, 2013 - sciendo.com
Background. Comparing initial 45 Gy of pelvic intensity-modulated radiation therapy (IMRT)
and non-IMRT in terms of the late toxicities associated with advanced cervical cancer that …

根治性调强放疗宫颈癌不同治疗模式的急性反应研究

赵潇, 周桂霞, 解传滨, 葛瑞刚, 巩汉顺… - 解放军医学院 …, 2012 - xuebao.301hospital.com.cn
目的回顾性分析调强放疗宫颈癌不同治疗模式改变及缩短总治疗时间的可行性及急性反应差异.
方法107 例根治性放疗宫颈癌患者, 外照射用三维适形放疗(three-dimensional conformal …

Rectal dose is the other dosimetric factor in addition to small bowel for prediction of acute diarrhea during postoperative whole-pelvic intensity-modulated radiotherapy …

EY Huang, YM Wang, SC Chang, SY Liu, MC Chou - Cancers, 2021 - mdpi.com
Simple Summary Although the small bowel volume effect for acute diarrhea during
radiotherapy has been investigated, no study has reported the influence of rectal dose. We …

Treatment outcome of the combination therapy of high-dose rate intracavitary brachytherapy and intensity-modulated radiation therapy with central-shielding for …

Y Mukai, Y Minagawa, H Inoue, A Sato, K Matsui… - in vivo, 2020 - iv.iiarjournals.org
Background/Aim: This study aimed to evaluate the clinical outcome of intensity-modulated
radiation therapy (IMRT) and high-dose-rate intracavitary brachytherapy (HDR-ICBT) in …